Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013)

Saudi Arabia flag Saudi Arabia · Delayed Price · Currency is SAR
213.80
-0.20 (-0.09%)
Jun 25, 2026, 3:17 PM AST
-19.32%
Market Cap 74.83B
Revenue (ttm) 13.98B
Net Income (ttm) 2.35B
Shares Out 350.00M
EPS (ttm) 6.71
PE Ratio 31.87
Forward PE 26.90
Dividend 4.83 (2.26%)
Ex-Dividend Date May 10, 2026
Volume 252,298
Average Volume 202,678
Open 214.00
Previous Close 214.00
Day's Range 213.60 - 216.70
52-Week Range 211.50 - 281.20
Beta 0.05
RSI 40.40
Earnings Date Jul 27, 2026

About TADAWUL:4013

Dr. Sulaiman Al Habib Medical Services Group Company, together with its subsidiaries, provides private health and support services in the Kingdom of Saudi Arabia. It operates through three segments: Hospitals/Healthcare Facilities, Pharmacies, and Other Solutions Sector. The company establishes, manages, and operates hospitals, general and specialized medical complexes, day surgery centers, and pharmaceutical facilities. It also provides home medical care; specialized medical laboratories; information technology and systems; facility maintenanc... [Read more]

Sector Healthcare
Founded 1993
Employees 10,475
Stock Exchange Saudi Stock Exchange
Ticker Symbol 4013
Full Company Profile

Financial Performance

In 2025, TADAWUL:4013's revenue was 13.71 billion, an increase of 22.38% compared to the previous year's 11.20 billion. Earnings were 2.40 billion, an increase of 3.72%.

Financial Statements

Analyst Forecast

According to 14 analysts, the average rating for 4013 stock is "Buy." The 12-month stock price target is SAR 270.54, which is an increase of 26.54% from the latest price.

Price Target
SAR 270.54
(26.54% upside)
Analyst Consensus: Buy
Stock Forecasts

News

There is no news available yet.